What is ESGEN Acquisition's operating income?

ESGEN Acquisition's total operating income in 2025 was -$20.53 million, based on the following breakdown: Total Gross Profit: $38.28 million Total Operating Expenses: $58.82 million

ESGEN Acquisition (ESACW) Financials

$0.03 0.00 (0.00%)

As of 07/16/2026

Compare

Annual Income Statements for ESGEN Acquisition

This table shows ESGEN Acquisition's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024	2025
Period end date	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	14	4.85	-2.67	-14
Consolidated Net Income / (Loss)	14	4.85	-9.87	-20
Net Income / (Loss) Continuing Operations	14	4.85	-9.87	-20
Total Pre-Tax Income	14	4.85	-11	-19
Total Operating Income	-2.83	5.14	-11	-21
Total Gross Profit	0.00	50	35	38
Total Revenue	0.00	110	73	69
Operating Revenue	-	110	73	69
Total Cost of Revenue	0.00	59	38	31
Operating Cost of Revenue	-	59	38	31
Total Operating Expenses	2.83	45	46	59
Selling, General & Admin Expense	0.80	13	22	28
Marketing Expense	-	30	20	23
Depreciation Expense	-	1.84	4.84	8.58
Other Special Charges / (Income)	1.91	-	-0.09	0.00
Total Other Income / (Expense), net	17	-0.29	-0.12	1.17
Interest Expense	-	0.11	0.33	0.16
Other Income / (Expense), net	13	-0.18	0.21	1.32
Income Tax Expense	-	0.00	-0.96	0.26
Net Income / (Loss) Attributable to Noncontrolling Interest	-	0.00	-6.68	-5.62
Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders)	-	0.00	-0.52	0.00
Basic Earnings per Share	$0.74	$4.85	($0.48)	($0.56)
Weighted Average Basic Shares Outstanding	34.50M	1M	5.55M	24.94M
Diluted Earnings per Share	-	$4.85	($0.48)	($0.56)
Weighted Average Diluted Shares Outstanding	9.80M	1M	5.55M	24.94M
Weighted Average Basic & Diluted Shares Outstanding	9.80M	40.26M	-	57.97M

This table shows ESGEN Acquisition's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Income / (Loss) Attributable to Common Shareholders	0.00	4.85	-1.53	-0.28	-0.42	-0.44	-6.36	-2.42	-3.23	-2.01	-3.51
Consolidated Net Income / (Loss)	4.00	-1.60	-4.11	-1.76	-2.87	-1.14	-13	-2.68	-1.87	-1.76	-4.69
Net Income / (Loss) Continuing Operations	4.00	-1.60	-4.11	-1.76	-2.87	-1.14	-13	-2.68	-1.87	-1.76	-4.69
Total Pre-Tax Income	4.00	-1.60	-4.22	-1.83	-2.92	-1.86	-13	-2.87	-1.82	-1.88	-4.78
Total Operating Income	4.00	-1.36	-4.05	-2.66	-2.98	-1.11	-14	-2.85	-1.98	-2.19	-4.77
Total Gross Profit	38	-7.68	6.18	7.74	9.87	11	3.99	11	14	9.63	5.60
Total Revenue	38	23	20	15	20	19	8.78	18	24	19	13
Operating Revenue	38	23	20	15	20	19	8.78	18	24	19	13
Total Cost of Revenue	0.00	31	14	7.06	9.79	7.26	4.79	7.28	10	8.94	7.58
Operating Cost of Revenue	-	-	14	7.06	9.79	7.26	4.79	7.28	10	8.94	7.58
Total Operating Expenses	34	-6.32	10	10	13	12	18	14	16	12	10
Selling, General & Admin Expense	25	-17	3.22	5.52	7.15	5.66	9.49	4.87	5.99	6.22	6.28
Marketing Expense	8.60	11	6.55	4.42	5.20	3.41	3.11	5.63	9.59	5.34	3.01
Depreciation Expense	0.52	0.41	0.46	0.45	0.50	3.42	4.90	3.18	0.25	0.25	1.08
Total Other Income / (Expense), net	-0.00	-0.24	-0.17	0.83	0.07	-0.85	0.72	-0.01	0.16	0.30	-0.02
Interest Expense	0.01	0.05	0.04	0.05	0.21	0.04	0.03	-0.03	0.13	0.03	0.01
Other Income / (Expense), net	0.01	-0.19	-0.14	0.88	0.28	-0.81	0.75	-0.04	0.29	0.33	-0.01
Income Tax Expense	0.00	-	-0.11	-0.08	-0.04	-0.73	0.52	-0.19	0.05	-0.12	-0.09
Net Income / (Loss) Attributable to Noncontrolling Interest	0.00	-	-2.05	-1.48	-2.45	-0.70	-6.96	-0.26	1.36	0.25	-1.18
Basic Earnings per Share	$0.00	$4.85	($1.54)	($0.06)	($0.08)	$1.20	($0.48)	($0.11)	($0.12)	$0.15	($0.11)
Weighted Average Basic Shares Outstanding	0.00	1M	994.35K	5.03M	5.05M	5.55M	13.25M	22.10M	27.31M	24.94M	33.38M
Diluted Earnings per Share	$0.00	$4.85	($1.54)	($0.06)	($0.08)	$1.20	($0.48)	($0.11)	($0.12)	$0.15	($0.11)
Weighted Average Diluted Shares Outstanding	0.00	1M	994.35K	5.03M	5.05M	5.55M	13.25M	22.10M	27.31M	24.94M	33.38M
Weighted Average Basic & Diluted Shares Outstanding	8.31M	40.26M	41.04M	41.04M	-	0.00	49.30M	54.83M	57.53M	57.97M	58.02M

This table details how cash moves in and out of ESGEN Acquisition's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024	2025
Period end date	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Change in Cash & Equivalents	-0.71	5.75	-2.39	0.50
Net Cash From Operating Activities	3.28	12	-8.72	-8.69
Net Cash From Continuing Operating Activities	3.28	12	-8.72	-8.69
Net Income / (Loss) Continuing Operations	14	4.85	-9.87	-20
Consolidated Net Income / (Loss)	14	4.85	-9.87	-20
Depreciation Expense	-	1.84	4.84	8.58
Amortization Expense	-	-	0.00	0.06
Non-Cash Adjustments To Reconcile Net Income	-13	-2.10	10	7.21
Changes in Operating Assets and Liabilities, net	2.12	7.39	-14	-4.91
Net Cash From Investing Activities	-3.98	-1.03	-7.37	13
Net Cash From Continuing Investing Activities	-3.98	-1.03	-7.37	13
Purchase of Property, Plant & Equipment	-	-1.03	-0.37	-1.22
Acquisitions	-	-	-4.00	0.00
Divestitures	-	-	0.00	15
Other Investing Activities, net	-	0.00	-3.00	0.00
Net Cash From Financing Activities	0.00	-5.19	14	-4.17
Net Cash From Continuing Financing Activities	0.00	-5.19	14	-4.17
Repayment of Debt	-	-0.24	-0.33	-3.38
Payment of Dividends	-	-5.17	-0.23	-0.62
Issuance of Debt	0.00	0.31	2.44	0.00
Issuance of Preferred Equity	-	0.00	9.22	0.00
Issuance of Common Equity	-	0.00	2.72	0.00
Other Financing Activities, net	-	-0.08	-0.12	-0.17
Cash Interest Paid	-	0.10	0.12	0.10
Cash Income Taxes Paid	-	0.00	0.00	0.00

This table details how cash moves in and out of ESGEN Acquisition's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Change in Cash & Equivalents	0.93	3.68	-0.29	-2.39	-1.01	1.30	-2.74	-2.83	3.85	2.22	-4.41
Net Cash From Operating Activities	3.82	6.31	-10	-2.20	0.16	3.47	-2.26	-2.29	-6.58	2.44	-0.85
Net Cash From Continuing Operating Activities	3.82	6.31	-10	-2.17	0.16	3.47	-2.26	-2.05	-6.82	2.44	-0.85
Net Income / (Loss) Continuing Operations	4.04	-1.60	-4.11	-1.76	-2.87	-1.14	-13	-2.68	-1.87	-1.76	-4.69
Consolidated Net Income / (Loss)	4.04	-1.60	-4.11	-1.76	-2.87	-1.14	-13	-2.68	-1.87	-1.76	-4.69
Depreciation Expense	0.44	0.48	0.46	0.45	0.50	3.42	4.89	3.18	0.25	0.25	1.08
Amortization Expense	-	-	-	-	-	-	0.02	-	-	0.02	0.00
Non-Cash Adjustments To Reconcile Net Income	1.64	-3.14	6.76	-1.29	5.72	-0.88	5.14	-1.85	-0.97	4.86	1.18
Changes in Operating Assets and Liabilities, net	-2.30	11	-13	0.43	-3.19	2.06	1.01	-0.69	-4.28	-0.92	1.58
Net Cash From Investing Activities	0.62	-0.87	-0.23	-0.10	0.05	-7.08	-0.37	-0.43	14	-0.18	-3.36
Net Cash From Continuing Investing Activities	0.62	-0.87	-0.23	-0.10	0.05	-7.08	-0.37	-0.43	14	-0.18	-3.36
Purchase of Property, Plant & Equipment	0.62	-0.87	-0.23	-0.10	0.05	-0.08	-0.37	-0.43	-0.24	-0.18	-0.21
Other Investing Activities, net	-	-	-	-	-	-	0.00	-	-	-	-3.15
Net Cash From Financing Activities	-3.51	-1.76	10	-0.08	-1.22	4.92	-0.10	-0.10	-3.92	-0.04	-0.20
Net Cash From Continuing Financing Activities	-3.51	-1.76	10	-0.08	-1.22	4.92	-0.10	-0.10	-3.92	-0.04	-0.20
Repayment of Debt	-0.19	0.09	-0.10	-0.03	-0.22	0.02	-0.10	-0.14	-3.14	-0.04	-0.04
Payment of Dividends	-2.76	-1.88	-0.09	-	-	-0.14	0.00	-	-0.62	-	-0.16
Issuance of Common Equity	-	-	-	-	-	-	0.00	-	-	-	0.01
Other Financing Activities, net	-	-	-	-	0.06	-0.12	0.00	-	-	-0.01	-0.01
Cash Interest Paid	0.00	0.06	0.03	0.03	0.08	-0.01	0.03	0.02	0.04	0.01	0.01
Cash Income Taxes Paid	-	-	0.00	-	-	-	0.00	-	-	-	0.00

This table presents ESGEN Acquisition's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2021	2022	2023	2024	2025
Period end date	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Total Assets	283	286	48	61	57
Total Current Assets	1.87	0.65	16	19	23
Cash & Equivalents	1.32	0.61	8.02	5.63	6.14
Accounts Receivable	-	-	2.91	9.19	8.77
Inventories, net	-	-	0.35	0.87	0.85
Prepaid Expenses	0.55	0.03	0.04	2.11	4.19
Other Current Assets	-	-	4.92	1.09	2.60
Plant, Property, & Equipment, net	0.00	0.00	2.29	2.48	2.83
Total Noncurrent Assets	282	286	30	40	32
Noncurrent Note & Lease Receivables	-	-	0.58	3.45	3.46
Goodwill	-	-	27	27	27
Other Noncurrent Operating Assets	282	-	1.20	1.34	0.99
Total Liabilities & Shareholders' Equity	283	286	48	61	57
Total Liabilities	24	13	17	18	9.45
Total Current Liabilities	0.61	2.18	16	15	8.39
Short-Term Debt	0.17	0.17	0.29	3.31	0.71
Accounts Payable	-	1.87	4.70	2.78	3.77
Accrued Expenses	0.41	-	4.65	8.54	2.47
Other Current Liabilities	0.02	0.14	0.66	0.33	1.44
Total Noncurrent Liabilities	24	10	1.94	3.09	1.06
Long-Term Debt	-	-	0.83	0.50	0.06
Capital Lease Obligations	-	-	0.48	1.15	0.51
Other Noncurrent Operating Liabilities	24	10	0.64	1.45	0.49
Redeemable Noncontrolling Interest	282	286	-	16	17
Total Equity & Noncontrolling Interests	-22	-12	31	27	30
Total Preferred & Common Equity	-22	-12	31	-89	5.33
Total Common Equity	-22	-12	31	27	30
Common Stock	0.00	0.00	31	130	88
Retained Earnings	-22	-12	-0.53	-103	-58
Accumulated Other Comprehensive Income / (Loss)	-	-	-	0.00	-0.00

This table presents ESGEN Acquisition's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026
Period end date	9/30/2023	3/31/2024	6/30/2024	9/30/2024	3/31/2025	6/30/2025	9/30/2025	3/31/2026
Total Assets	33	50	47	47	47	46	59	57
Total Current Assets	0.27	18	16	16	10	11	24	20
Cash & Equivalents	0.27	7.73	5.34	4.33	2.89	0.07	3.92	1.73
Accounts Receivable	-	7.75	7.53	8.52	5.00	5.55	11	11
Inventories, net	-	0.38	0.44	0.48	0.85	0.92	0.93	0.85
Prepaid Expenses	0.00	2.60	2.72	2.25	0.94	1.58	1.59	3.98
Other Current Assets	-	-	-	-	0.58	2.78	6.09	2.34
Plant, Property, & Equipment, net	0.00	2.35	2.29	2.13	2.63	2.85	2.87	1.99
Total Noncurrent Assets	32	29	29	29	32	32	29	35
Noncurrent Note & Lease Receivables	-	0.55	0.52	0.48	0.41	3.38	0.34	6.62
Goodwill	-	27	27	27	27	27	27	27
Other Noncurrent Operating Assets	32	1.22	1.15	1.89	1.20	2.10	1.16	0.80
Total Liabilities & Shareholders' Equity	33	50	47	47	47	46	59	57
Total Liabilities	8.02	16	12	14	16	16	12	13
Total Current Liabilities	7.02	11	8.40	10	14	14	11	12
Short-Term Debt	1.41	0.30	0.31	0.29	2.76	3.34	2.51	0.64
Accounts Payable	5.30	5.45	3.39	4.86	3.57	5.05	3.45	5.01
Accrued Expenses	-	3.90	3.76	3.56	6.58	5.47	2.84	5.70
Other Current Liabilities	0.31	0.61	0.51	0.70	0.69	0.34	0.86	0.77
Total Noncurrent Liabilities	1.00	4.88	3.90	3.55	2.18	2.07	33	0.98
Long-Term Debt	-	0.75	0.69	0.57	0.41	0.34	0.06	0.05
Capital Lease Obligations	-	0.45	0.42	0.38	0.31	0.85	-	0.37
Other Noncurrent Operating Liabilities	1.00	3.69	2.80	2.60	1.45	0.88	32	0.57
Redeemable Noncontrolling Interest	32	15	15	16	17	17	17	17
Total Equity & Noncontrolling Interests	-7.75	19	19	18	15	13	-1.72	26
Total Preferred & Common Equity	-7.75	-173	-53	-39	-23	-59	-1.72	14
Total Common Equity	-7.75	19	19	18	15	13	-1.72	26
Common Stock	0.00	192	75	61	55	109	60	77
Retained Earnings	-7.75	-173	-55	-43	-40	-96	-62	-51
Accumulated Other Comprehensive Income / (Loss)	-	-	-	-	-	-	-0.00	0.01

This table displays calculated financial ratios and metrics derived from ESGEN Acquisition's official financial filings.

Metric	2022	2023	2024	2025
Period end date	12/31/2022	12/31/2023	12/31/2024	12/31/2025
DEI Shares Outstanding	34,500,000.00	8,308,555.00	40,256,964.00	40,256,964.00
DEI Adjusted Shares Outstanding	34,500,000.00	8,308,555.00	40,256,964.00	40,256,964.00
DEI Earnings Per Adjusted Shares Outstanding	0.42	0.58	-0.07	-0.35
Growth Metrics	-	-	-	-
Revenue Growth	0.00%	0.00%	-33.23%	-5.32%
EBITDA Growth	0.00%	-34.32%	-184.70%	-83.65%
EBIT Growth	0.00%	-52.12%	-313.77%	-81.33%
NOPAT Growth	0.00%	281.59%	-247.17%	-90.03%
Net Income Growth	0.00%	-66.20%	-303.76%	-98.83%
EPS Growth	0.00%	0.00%	-109.90%	-16.67%
Operating Cash Flow Growth	0.00%	265.68%	-172.78%	0.29%
Free Cash Flow Firm Growth	0.00%	0.00%	18.72%	42.38%
Invested Capital Growth	0.00%	294.59%	74.54%	0.90%
Revenue Q/Q Growth	0.00%	26.51%	-5.59%	-0.12%
EBITDA Q/Q Growth	0.00%	-0.18%	30.95%	-41.86%
EBIT Q/Q Growth	0.00%	-27.23%	-3.59%	-0.04%
NOPAT Q/Q Growth	0.00%	-1.77%	2.24%	-5.40%
Net Income Q/Q Growth	0.00%	-46.80%	4.46%	-3.29%
EPS Q/Q Growth	0.00%	0.00%	-115.14%	-214.29%
Operating Cash Flow Q/Q Growth	0.00%	27.75%	-48.28%	-13.46%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	-106.53%	-341.60%
Invested Capital Q/Q Growth	0.00%	-6.17%	38.71%	298.00%
Profitability Metrics	-	-	-	-
Gross Margin	0.00%	45.81%	48.03%	55.20%
EBITDA Margin	0.00%	6.20%	-7.86%	-15.25%
Operating Margin	0.00%	4.69%	-14.75%	-29.61%
EBIT Margin	0.00%	4.52%	-14.46%	-27.70%
Profit (Net Income) Margin	0.00%	4.42%	-13.48%	-28.31%
Tax Burden Percent	100.00%	100.00%	91.11%	101.36%
Interest Burden Percent	138.50%	97.76%	102.28%	100.81%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	0.00%	87.38%	-22.77%	-33.88%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	87.58%	42.30%	156.06%
Return on Net Nonoperating Assets (RNNOA)	0.00%	-84.19%	-4.08%	-9.56%
Return on Equity (ROE)	5.38%	3.19%	-26.85%	-43.43%
Cash Return on Invested Capital (CROIC)	0.00%	-130.15%	-77.07%	-34.77%
Operating Return on Assets (OROA)	0.00%	2.97%	-19.43%	-32.59%
Return on Assets (ROA)	0.00%	2.90%	-18.10%	-33.30%
Return on Common Equity (ROCE)	-0.35%	0.20%	-20.96%	-27.41%
Return on Equity Simple (ROE_SIMPLE)	-119.52%	15.82%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	-2.83	5.14	-7.56	-14
NOPAT Margin	0.00%	4.69%	-10.33%	-20.72%
Net Nonoperating Expense Percent (NNEP)	6.00%	-0.20%	-65.06%	-189.94%
Return On Investment Capital (ROIC_SIMPLE)	-	15.95%	-23.83%	-45.56%
Cost of Revenue to Revenue	0.00%	54.19%	51.97%	44.80%
SG&A Expenses to Revenue	0.00%	11.81%	29.43%	39.71%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	0.00%	41.13%	62.65%	84.81%
Earnings before Interest and Taxes (EBIT)	10	4.96	-11	-19
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	10	6.80	-5.76	-11
Valuation Ratios	-	-	-	-
Price to Book Value (P/BV)	0.00	0.37	0.71	0.90
Price to Tangible Book Value (P/TBV)	0.00	3.96	0.00	8.55
Price to Revenue (P/Rev)	0.00	0.10	0.26	0.39
Price to Earnings (P/E)	7.07	2.32	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%
Earnings Yield	14.15%	43.03%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.20	0.82	0.93
Enterprise Value to Revenue (EV/Rev)	0.00	0.04	0.47	0.57
Enterprise Value to EBITDA (EV/EBITDA)	9.74	0.71	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	9.74	0.98	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.94	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	30.79	0.40	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-
Debt to Equity	0.00	0.05	0.12	0.03
Long-Term Debt to Equity	0.00	0.04	0.04	0.01
Financial Leverage	-1.05	-0.96	-0.10	-0.06
Leverage Ratio	1.07	1.10	1.48	1.30
Compound Leverage Factor	1.48	1.07	1.52	1.32
Debt to Total Capital	0.06%	4.96%	10.36%	2.62%
Short-Term Debt to Total Capital	0.06%	0.91%	6.92%	1.45%
Long-Term Debt to Total Capital	0.00%	4.05%	3.44%	1.17%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	104.32%	0.00%	33.70%	35.29%
Common Equity to Total Capital	-4.38%	95.04%	55.94%	62.09%
Debt to EBITDA	0.02	0.24	-0.86	-0.12
Net Debt to EBITDA	-27.63	-0.94	0.12	0.46
Long-Term Debt to EBITDA	0.00	0.19	-0.29	-0.05
Debt to NOPAT	-0.06	0.31	-0.66	-0.09
Net Debt to NOPAT	101.04	-1.25	0.09	0.34
Long-Term Debt to NOPAT	0.00	0.25	-0.22	-0.04
Altman Z-Score	4.86	3.01	-1.04	0.70
Noncontrolling Interest Sharing Ratio	106.45%	93.87%	21.94%	36.88%
Liquidity Ratios	-	-	-	-
Current Ratio	0.30	1.05	1.26	2.69
Quick Ratio	0.28	0.70	0.99	1.78
Cash Flow Metrics	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	-31	-26	-15
Operating Cash Flow to CapEx	0.00%	1,157.58%	-2,361.38%	-710.43%
Free Cash Flow to Firm to Interest Expense	0.00	-284.12	-76.76	-94.87
Operating Cash Flow to Interest Expense	0.00	108.04	-26.13	-55.90
Operating Cash Flow Less CapEx to Interest Expense	0.00	98.71	-27.24	-63.77
Efficiency Ratios	-	-	-	-
Asset Turnover	0.00	0.66	1.34	1.18
Accounts Receivable Turnover	0.00	0.00	12.11	7.72
Inventory Turnover	0.00	0.00	62.26	36.03
Fixed Asset Turnover	0.00	0.00	30.74	26.14
Accounts Payable Turnover	0.00	18.10	10.18	9.49
Days Sales Outstanding (DSO)	0.00	0.00	30.13	47.26
Days Inventory Outstanding (DIO)	0.00	0.00	5.86	10.13
Days Payable Outstanding (DPO)	0.00	20.16	35.86	38.48
Cash Conversion Cycle (CCC)	0.00	-20.16	0.13	18.91
Capital & Investment Metrics	-	-	-	-
Invested Capital	-12	24	42	43
Invested Capital Turnover	0.00	18.65	2.20	1.63
Increase / (Decrease) in Invested Capital	0.00	37	18	0.38
Enterprise Value (EV)	101	4.84	34	40
Market Capitalization	101	11	19	27
Book Value per Share	($0.35)	$3.69	$4.83	$1.21
Tangible Book Value per Share	($0.35)	$0.34	($1.41)	$0.13
Total Capital	274	32	48	49
Total Debt	0.17	1.60	4.96	1.28
Total Long-Term Debt	0.00	1.31	1.64	0.57
Net Debt	-286	-6.42	-0.67	-4.86
Capital Expenditures (CapEx)	0.00	1.03	0.37	1.22
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-1.98	-7.02	1.60	8.73
Debt-free Net Working Capital (DFNWC)	-1.37	1.01	7.23	15
Net Working Capital (NWC)	-1.54	0.71	3.92	14
Net Nonoperating Expense (NNE)	-17	0.29	2.31	5.26
Net Nonoperating Obligations (NNO)	-286	-6.42	-0.67	-4.86
Total Depreciation and Amortization (D&A)	0.00	1.84	4.84	8.64
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	-6.40%	2.18%	12.59%
Debt-free Net Working Capital to Revenue	0.00%	0.92%	9.88%	21.44%
Net Working Capital to Revenue	0.00%	0.65%	5.35%	20.42%
Earnings Adjustments	-	-	-	-
Adjusted Basic Earnings per Share	$0.74	$0.00	($0.48)	($0.56)
Adjusted Weighted Average Basic Shares Outstanding	34.50M	0.00	5.55M	24.94M
Adjusted Diluted Earnings per Share	$0.74	$0.00	($0.48)	($0.56)
Adjusted Weighted Average Diluted Shares Outstanding	34.50M	0.00	5.55M	24.94M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	9.80M	0.00	0.00	57.97M
Normalized Net Operating Profit after Tax (NOPAT)	-0.64	3.60	-7.63	-14
Normalized NOPAT Margin	0.00%	3.28%	-10.41%	-20.72%
Pre Tax Income Margin	0.00%	4.42%	-14.79%	-27.93%
Debt Service Ratios	-	-	-	-
EBIT to Interest Expense	0.00	44.71	-31.76	-123.55
NOPAT to Interest Expense	0.00	46.36	-22.68	-92.43
EBIT Less CapEx to Interest Expense	0.00	35.37	-32.87	-131.42
NOPAT Less CapEx to Interest Expense	0.00	37.03	-23.78	-100.30
Payout Ratios	-	-	-	-
Dividend Payout Ratio	0.00%	106.78%	-2.32%	-3.16%
Augmented Payout Ratio	0.00%	106.78%	-2.32%	-3.16%

This table displays calculated financial ratios and metrics derived from ESGEN Acquisition's official financial filings.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
DEI Shares Outstanding	9,796,555.00	8,308,555.00	40,256,964.00	40,256,964.00	40,256,964.00	40,256,964.00	40,256,964.00	40,256,964.00	40,256,964.00	40,256,964.00	40,256,964.00
DEI Adjusted Shares Outstanding	9,796,555.00	8,308,555.00	40,256,964.00	40,256,964.00	40,256,964.00	40,256,964.00	40,256,964.00	40,256,964.00	40,256,964.00	40,256,964.00	40,256,964.00
DEI Earnings Per Adjusted Shares Outstanding	0.00	0.58	-0.04	-0.01	-0.01	-0.01	-0.16	-0.06	-0.08	-0.05	-0.09
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	0.00%	0.00%	7.53%	-50.81%	-48.12%	-18.87%	-56.39%	22.34%	21.56%	-0.43%	50.11%
EBITDA Growth	47.70%	-410.97%	-281.20%	-201.01%	-149.55%	240.37%	-111.02%	120.97%	34.70%	-205.61%	53.07%
EBIT Growth	32.96%	-548.59%	-356.35%	-307.16%	-167.51%	-23.73%	-204.92%	-62.35%	37.54%	3.07%	62.61%
NOPAT Growth	1,315.18%	22.44%	-274.07%	-314.66%	-152.18%	18.25%	-233.73%	-7.16%	33.60%	-96.91%	64.73%
Net Income Growth	-6.15%	-159.21%	-354.67%	-311.97%	-171.81%	28.89%	-224.30%	-52.47%	34.92%	-55.11%	64.78%
EPS Growth	0.00%	0.00%	0.00%	0.00%	0.00%	-75.26%	68.83%	-83.33%	-50.00%	-87.50%	77.08%
Operating Cash Flow Growth	6,772.78%	70.15%	-768.41%	-710.93%	-95.75%	-44.97%	77.70%	-3.94%	-4,158.19%	-29.70%	62.32%
Free Cash Flow Firm Growth	192.07%	0.00%	-105.84%	-103.40%	-102.72%	49.94%	27.66%	34.49%	372.04%	89.85%	-60.67%
Invested Capital Growth	-90.45%	294.59%	72.00%	25.83%	18.07%	74.54%	3.88%	10.94%	-64.84%	0.90%	46.70%
Revenue Q/Q Growth	25.98%	-39.34%	-12.37%	-26.54%	32.86%	-5.14%	-52.90%	106.09%	32.01%	-22.30%	-28.99%
EBITDA Q/Q Growth	239.87%	-124.10%	-247.13%	64.30%	-65.93%	168.27%	-621.85%	103.55%	-616.68%	-10.41%	-131.91%
EBIT Q/Q Growth	388.34%	-138.62%	-170.30%	57.39%	-51.75%	29.22%	-566.14%	77.31%	41.62%	-9.84%	-156.94%
NOPAT Q/Q Growth	383.01%	-123.77%	-198.03%	34.23%	-12.02%	62.77%	-1,116.70%	78.88%	30.59%	-10.41%	-117.91%
Net Income Q/Q Growth	401.73%	-139.92%	-157.21%	57.21%	-63.45%	60.47%	-1,072.98%	79.88%	30.23%	5.78%	-166.35%
EPS Q/Q Growth	0.00%	0.00%	-131.75%	96.10%	-33.33%	1,600.00%	-140.00%	77.08%	-9.09%	225.00%	-173.33%
Operating Cash Flow Q/Q Growth	1,371.09%	65.33%	-260.87%	78.33%	107.37%	2,040.87%	-165.18%	-1.02%	-187.91%	137.09%	-134.93%
Free Cash Flow Firm Q/Q Growth	2.63%	-115.14%	61.21%	43.54%	18.02%	-178.86%	43.95%	48.88%	440.44%	-110.40%	-787.68%
Invested Capital Q/Q Growth	4.61%	-6.17%	15.94%	10.56%	-1.84%	38.71%	-31.00%	18.07%	-68.89%	298.00%	0.33%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	100.00%	-33.40%	30.70%	52.29%	50.21%	61.06%	45.47%	59.76%	57.93%	51.86%	42.51%
EBITDA Margin	11.76%	-4.67%	-18.50%	-8.99%	-11.23%	8.08%	-89.54%	1.54%	-6.03%	-8.57%	-27.99%
Operating Margin	10.56%	-5.91%	-20.10%	-18.00%	-15.17%	-5.96%	-153.82%	-15.76%	-8.29%	-11.78%	-36.14%
EBIT Margin	10.58%	-6.74%	-20.79%	-12.06%	-13.77%	-10.28%	-145.33%	-16.00%	-7.08%	-10.00%	-36.20%
Profit (Net Income) Margin	10.56%	-6.95%	-20.39%	-11.88%	-14.61%	-6.09%	-151.64%	-14.80%	-7.82%	-9.49%	-35.58%
Tax Burden Percent	100.00%	100.00%	97.28%	95.83%	98.49%	60.92%	104.09%	93.48%	102.68%	93.54%	98.07%
Interest Burden Percent	99.74%	103.10%	100.84%	102.79%	107.73%	97.27%	100.24%	98.96%	107.67%	101.37%	100.23%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	6.19%	-77.15%	-70.46%	-43.36%	-29.31%	-9.19%	-232.98%	-21.99%	-19.57%	-13.48%	-51.90%
ROIC Less NNEP Spread (ROIC-NNEP)	5.60%	-76.71%	-28.82%	-49.84%	51.31%	0.90%	-143.64%	-281.37%	-6.58%	-5.14%	35.90%
Return on Net Nonoperating Assets (RNNOA)	0.01%	73.74%	3.49%	2.79%	-1.72%	-0.09%	18.86%	-2.28%	1.01%	0.31%	-1.48%
Return on Equity (ROE)	6.20%	-3.41%	-66.97%	-40.58%	-31.02%	-9.28%	-214.12%	-24.27%	-18.57%	-13.16%	-53.38%
Cash Return on Invested Capital (CROIC)	0.00%	-130.15%	-54.63%	-33.10%	-44.08%	-77.07%	-53.41%	-54.20%	29.67%	-34.77%	-60.81%
Operating Return on Assets (OROA)	5.79%	-4.42%	-56.95%	-29.27%	-26.79%	-13.80%	-184.42%	-22.32%	-9.31%	-11.77%	-51.35%
Return on Assets (ROA)	5.78%	-4.56%	-55.87%	-28.83%	-28.43%	-8.18%	-192.42%	-20.65%	-10.29%	-11.16%	-50.47%
Return on Common Equity (ROCE)	-0.42%	-0.21%	-5.95%	-8.17%	-5.29%	-7.24%	-111.32%	-12.15%	-6.10%	-8.31%	-29.16%
Return on Equity Simple (ROE_SIMPLE)	-117.57%	0.00%	0.51%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	4.00	-0.95	-2.83	-1.86	-2.09	-0.78	-9.46	-2.00	-1.39	-1.53	-3.34
NOPAT Margin	10.56%	-4.14%	-14.07%	-12.60%	-10.62%	-4.17%	-107.68%	-11.03%	-5.80%	-8.24%	-25.30%
Net Nonoperating Expense Percent (NNEP)	0.59%	-0.44%	-41.65%	6.47%	-80.62%	-10.09%	-89.34%	259.38%	-13.00%	-8.33%	-87.80%
Return On Investment Capital (ROIC_SIMPLE)	-63.15%	-2.95%	-13.68%	-8.92%	-11.04%	-2.45%	-51.11%	-11.40%	-163.43%	-4.85%	-12.35%
Cost of Revenue to Revenue	0.00%	133.40%	69.30%	47.71%	49.79%	38.94%	54.53%	40.24%	42.07%	48.14%	57.49%
SG&A Expenses to Revenue	65.38%	-75.00%	15.98%	37.33%	36.38%	30.37%	108.06%	26.88%	25.05%	33.51%	47.61%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	89.44%	-27.49%	50.80%	70.28%	65.39%	66.52%	199.29%	75.52%	66.22%	63.64%	78.65%
Earnings before Interest and Taxes (EBIT)	4.01	-1.55	-4.19	-1.78	-2.71	-1.92	-13	-2.90	-1.69	-1.86	-4.77
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	4.45	-1.07	-3.73	-1.33	-2.21	1.51	-7.86	0.28	-1.44	-1.59	-3.69
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.37	0.30	0.55	0.48	0.71	1.33	4.93	0.00	0.90	0.74
Price to Tangible Book Value (P/TBV)	0.00	3.96	0.00	0.00	0.00	0.00	0.00	0.00	0.00	8.55	0.00
Price to Revenue (P/Rev)	0.00	0.10	0.05	0.11	0.11	0.26	0.32	0.98	0.53	0.39	0.26
Price to Earnings (P/E)	0.00	2.32	1.71	3.56	3.27	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	43.03%	58.46%	28.09%	30.58%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.20	0.52	0.72	0.70	0.82	1.27	2.48	4.88	0.93	0.84
Enterprise Value to Revenue (EV/Rev)	0.00	0.04	0.13	0.23	0.27	0.47	0.60	1.31	0.75	0.57	0.49
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.71	14.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.98	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.94	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.40	47.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	8.57	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.06	0.05	0.04	0.04	0.04	0.12	0.11	0.15	0.17	0.03	0.02
Long-Term Debt to Equity	0.00	0.04	0.03	0.03	0.03	0.04	0.02	0.04	0.00	0.01	0.01
Financial Leverage	0.00	-0.96	-0.12	-0.06	-0.03	-0.10	-0.13	0.01	-0.15	-0.06	-0.04
Leverage Ratio	1.07	1.10	1.61	1.34	1.37	1.48	1.48	1.44	2.17	1.30	1.39
Compound Leverage Factor	1.07	1.13	1.62	1.38	1.48	1.44	1.48	1.43	2.34	1.32	1.39
Debt to Total Capital	5.41%	4.96%	4.18%	3.87%	3.57%	10.36%	9.94%	13.13%	14.58%	2.62%	2.37%
Short-Term Debt to Total Capital	5.41%	0.91%	0.84%	0.85%	0.84%	6.92%	7.87%	9.69%	14.23%	1.45%	1.43%
Long-Term Debt to Total Capital	0.00%	4.05%	3.34%	3.03%	2.73%	3.44%	2.08%	3.44%	0.35%	1.17%	0.94%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	124.32%	0.00%	42.13%	42.53%	45.61%	33.70%	47.19%	49.18%	95.19%	35.29%	39.29%
Common Equity to Total Capital	-29.73%	95.04%	53.69%	53.60%	50.82%	55.94%	42.86%	37.69%	-9.77%	62.09%	58.34%
Debt to EBITDA	0.21	0.24	1.48	-0.86	-0.15	-0.86	-0.35	-0.55	-0.34	-0.12	-0.16
Net Debt to EBITDA	0.17	-0.94	-6.15	2.41	0.37	0.12	-0.06	-0.54	0.18	0.46	0.11
Long-Term Debt to EBITDA	0.00	0.19	1.18	-0.67	-0.11	-0.29	-0.07	-0.14	-0.01	-0.05	-0.07
Debt to NOPAT	0.27	0.31	-3.98	-0.49	-0.16	-0.66	-0.25	-0.32	-0.19	-0.09	-0.13
Net Debt to NOPAT	0.22	-1.25	16.58	1.38	0.40	0.09	-0.04	-0.31	0.10	0.34	0.08
Long-Term Debt to NOPAT	0.00	0.25	-3.18	-0.39	-0.12	-0.22	-0.05	-0.08	0.00	-0.04	-0.05
Altman Z-Score	0.00	2.56	-2.50	0.98	0.69	-0.57	-0.08	0.56	1.66	1.71	0.80
Noncontrolling Interest Sharing Ratio	106.80%	93.87%	91.11%	79.87%	82.93%	21.94%	48.01%	49.95%	67.17%	36.88%	45.36%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.04	1.05	1.69	1.91	1.56	1.26	0.75	0.76	2.19	2.69	1.65
Quick Ratio	0.04	0.70	1.42	1.53	1.28	0.99	0.58	0.40	1.41	1.78	1.06
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	248	-38	-15	-8.23	-6.75	-19	-11	-5.39	18	-1.91	-17
Operating Cash Flow to CapEx	0.00%	722.97%	-4,490.52%	-2,099.95%	0.00%	4,130.86%	-607.51%	-526.30%	-2,735.66%	1,389.28%	-415.33%
Free Cash Flow to Firm to Interest Expense	23,885.04	-784.09	-413.90	-165.25	-32.25	-478.99	-348.34	0.00	141.50	-74.91	-1,561.39
Operating Cash Flow to Interest Expense	367.17	131.65	-288.23	-44.16	0.78	88.41	-74.76	0.00	-50.75	95.81	-78.58
Operating Cash Flow Less CapEx to Interest Expense	427.04	113.44	-294.65	-46.27	0.99	86.27	-87.06	0.00	-52.60	88.91	-97.50
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.55	0.66	2.74	2.43	1.95	1.34	1.27	1.39	1.32	1.18	1.42
Accounts Receivable Turnover	0.00	0.00	0.00	0.00	0.00	12.11	9.71	9.97	6.94	7.72	9.15
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	62.26	47.12	42.93	41.41	36.03	39.78
Fixed Asset Turnover	0.00	0.00	0.00	0.00	0.00	30.74	24.87	25.37	27.78	26.14	31.94
Accounts Payable Turnover	11.00	18.10	14.73	12.83	12.11	10.18	6.41	6.89	7.07	9.49	7.89
Days Sales Outstanding (DSO)	0.00	0.00	0.00	0.00	0.00	30.13	37.59	36.61	52.63	47.26	39.90
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	5.86	7.75	8.50	8.81	10.13	9.18
Days Payable Outstanding (DPO)	33.17	20.16	24.77	28.44	30.14	35.86	56.95	52.97	51.64	38.48	46.25
Cash Conversion Cycle (CCC)	-33.17	-20.16	-24.77	-28.44	-30.14	0.13	-11.62	-7.86	9.80	18.91	2.83
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	26	24	28	31	30	42	29	34	11	43	43
Invested Capital Turnover	0.59	18.65	5.01	3.44	2.76	2.20	2.16	1.99	3.37	1.63	2.05
Increase / (Decrease) in Invested Capital	-244	37	12	6.37	4.66	18	1.09	3.39	-20	0.38	14
Enterprise Value (EV)	0.00	4.84	15	22	21	34	37	85	52	40	36
Market Capitalization	0.00	11	5.67	11	8.54	19	20	64	37	27	19
Book Value per Share	($0.79)	$3.69	$19.32	$3.88	$3.50	$4.83	$1.13	$0.59	($0.06)	$1.21	$0.78
Tangible Book Value per Share	($0.79)	$0.34	($8.36)	($1.55)	($1.85)	($1.41)	($1.13)	($0.63)	($1.06)	$0.13	($0.03)
Total Capital	26	32	36	36	35	48	35	34	18	49	44
Total Debt	1.41	1.60	1.50	1.41	1.24	4.96	3.48	4.53	2.57	1.28	1.05
Total Long-Term Debt	0.00	1.31	1.20	1.10	0.95	1.64	0.73	1.19	0.06	0.57	0.42
Net Debt	1.14	-6.42	-6.23	-3.93	-3.09	-0.67	0.59	4.46	-1.35	-4.86	-0.68
Capital Expenditures (CapEx)	-0.62	0.87	0.23	0.10	-0.05	0.08	0.37	0.43	0.24	0.18	0.21
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-5.60	-7.02	0.10	2.59	1.54	1.60	-3.60	-0.12	12	8.73	6.82
Debt-free Net Working Capital (DFNWC)	-5.33	1.01	7.84	7.93	5.87	7.23	-0.70	-0.05	16	15	8.56
Net Working Capital (NWC)	-6.74	0.71	7.54	7.62	5.58	3.92	-3.46	-3.39	13	14	7.92
Net Nonoperating Expense (NNE)	0.00	0.65	1.27	-0.11	0.78	0.36	3.86	0.68	0.48	0.23	1.36
Net Nonoperating Obligations (NNO)	1.14	-6.42	-6.23	-3.93	-3.09	-0.67	-2.41	4.46	-4.35	-4.86	-0.68
Total Depreciation and Amortization (D&A)	0.44	0.48	0.46	0.45	0.50	3.42	4.90	3.18	0.25	0.27	1.08
Debt-free, Cash-free Net Working Capital to Revenue	-6.46%	-6.40%	0.09%	2.70%	1.98%	2.18%	-5.82%	-0.18%	16.70%	12.59%	9.25%
Debt-free Net Working Capital to Revenue	-6.15%	0.92%	7.05%	8.28%	7.56%	9.88%	-1.14%	-0.08%	22.34%	21.44%	11.60%
Net Working Capital to Revenue	-7.78%	0.65%	6.78%	7.96%	7.19%	5.35%	-5.59%	-5.21%	18.73%	20.42%	10.74%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$4.85	$0.00	$0.00	($0.08)	$1.20	($0.48)	($0.11)	($0.12)	$0.15	($0.11)
Adjusted Weighted Average Basic Shares Outstanding	9.80M	1M	0.00	0.00	5.05M	5.55M	13.25M	22.10M	27.31M	24.94M	33.38M
Adjusted Diluted Earnings per Share	$0.00	$4.85	$0.00	$0.00	($0.08)	$1.20	($0.48)	($0.11)	($0.12)	$0.15	($0.11)
Adjusted Weighted Average Diluted Shares Outstanding	9.80M	1M	0.00	0.00	5.05M	5.55M	13.25M	22.10M	27.31M	24.94M	33.38M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	8.31M	40.26M	0.00	0.00	0.00	0.00	49.30M	54.83M	57.53M	57.97M	58.02M
Normalized Net Operating Profit after Tax (NOPAT)	2.80	-0.95	-2.83	-1.86	-2.09	-0.78	-9.46	-2.00	-1.39	-1.53	-3.34
Normalized NOPAT Margin	7.39%	-4.14%	-14.07%	-12.60%	-10.62%	-4.17%	-107.68%	-11.03%	-5.80%	-8.24%	-25.30%
Pre Tax Income Margin	10.56%	-6.95%	-20.96%	-12.39%	-14.84%	-10.00%	-145.68%	-15.84%	-7.62%	-10.14%	-36.28%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	385.77	-32.31	-118.86	-35.82	-12.94	-48.78	-421.63	0.00	-13.04	-72.89	-439.75
NOPAT to Interest Expense	384.89	-19.84	-80.46	-37.42	-9.98	-19.79	-312.38	0.00	-10.69	-60.07	-307.34
EBIT Less CapEx to Interest Expense	445.64	-50.52	-125.28	-37.92	-12.72	-50.92	-433.93	0.00	-14.89	-79.79	-458.67
NOPAT Less CapEx to Interest Expense	444.76	-38.05	-86.88	-39.53	-9.76	-21.93	-324.69	0.00	-12.54	-66.96	-326.26
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	106.78%	-582.68%	-136.83%	-19.10%	-2.32%	-0.73%	-0.70%	-4.00%	-3.16%	-7.10%
Augmented Payout Ratio	0.00%	106.78%	-582.68%	-136.83%	-19.10%	-2.32%	-0.73%	-0.70%	-4.00%	-3.16%	-7.10%

Financials Breakdown Chart

ESGEN Acquisition Financials - Frequently Asked Questions

According to the most recent income statement we have on file, ESGEN Acquisition's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

ESGEN Acquisition's net income appears to be on an upward trend, with a most recent value of -$19.63 million in 2025, falling from $14.33 million in 2022. The previous period was -$9.87 million in 2024.

ESGEN Acquisition's total operating income in 2025 was -$20.53 million, based on the following breakdown:

Total Gross Profit: $38.28 million
Total Operating Expenses: $58.82 million

Over the last 3 years, ESGEN Acquisition's total revenue changed from $0.00 in 2022 to $69.35 million in 2025, a change of 6,934,993,800.0%.

ESGEN Acquisition's total liabilities were at $9.45 million at the end of 2025, a 47.7% decrease from 2024, and a 61.0% decrease since 2021.

In the past 4 years, ESGEN Acquisition's cash and equivalents has ranged from $614.77 thousand in 2022 to $8.02 million in 2023, and is currently $6.14 million as of their latest financial filing in 2025.

Over the last 3 years, ESGEN Acquisition's book value per share changed from -0.35 in 2022 to 1.21 in 2025, a change of -449.2%.

Related Companies

Financial statements for NASDAQ:ESACW last updated on 7/16/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

ESGEN Acquisition (ESACW) Financials

Financials Breakdown Chart

ESGEN Acquisition Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

ESGEN Acquisition (ESACW) Financials

Annual Income Statements for ESGEN Acquisition

Quarterly Income Statements for ESGEN Acquisition

Annual Cash Flow Statements for ESGEN Acquisition

Quarterly Cash Flow Statements for ESGEN Acquisition

Annual Balance Sheets for ESGEN Acquisition

Quarterly Balance Sheets for ESGEN Acquisition

Annual Metrics And Ratios for ESGEN Acquisition

Quarterly Metrics And Ratios for ESGEN Acquisition

Financials Breakdown Chart

ESGEN Acquisition Financials - Frequently Asked Questions

When does ESGEN Acquisition's fiscal year end?

How has ESGEN Acquisition's net income changed over the last 3 years?

What is ESGEN Acquisition's operating income?

How has ESGEN Acquisition's revenue changed over the last 3 years?

How much debt does ESGEN Acquisition have?

How much cash does ESGEN Acquisition have?

How has ESGEN Acquisition's book value per share changed over the last 3 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools